Bolt Biotherapeutics, Inc.
NASDAQ:BOLT
0.6218 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 10.81 | 9.244 | 27.383 | 5.542 | 34.826 | 13.634 |
| Short Term Investments
| 91.379 | 159.644 | 158.836 | 17.296 | 0 | 0 |
| Cash and Short Term Investments
| 102.189 | 168.888 | 186.219 | 22.838 | 34.826 | 13.634 |
| Net Receivables
| 1.3 | 0.8 | 0.2 | 0.012 | 0.3 | 0 |
| Inventory
| 0 | -0.8 | -0.2 | -0.012 | -0.3 | 0 |
| Other Current Assets
| 2.041 | 3.858 | 2.941 | 2.523 | 1.074 | 0.466 |
| Total Current Assets
| 105.53 | 172.746 | 189.16 | 25.361 | 35.9 | 14.1 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 24.077 | 28.525 | 30.603 | 16.384 | 11.517 | 1.442 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 28.178 | 23.943 | 85.348 | 1.565 | 0.584 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.999 | 2.593 | 2.607 | 3.232 | 0.446 | 0.433 |
| Total Non-Current Assets
| 54.254 | 55.061 | 118.558 | 21.181 | 12.547 | 1.875 |
| Total Assets
| 159.784 | 227.807 | 307.718 | 46.542 | 48.447 | 15.975 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.987 | 3.594 | 3.574 | 1.598 | 2.095 | 0.892 |
| Short Term Debt
| 2.782 | 2.391 | 2.501 | 1.501 | 3.096 | 0.04 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 2.201 | 1.993 | 2.869 | 1.502 | 0.599 | 0 |
| Other Current Liabilities
| 12.486 | 15.14 | 12.384 | 6.663 | 2.866 | 1.823 |
| Total Current Liabilities
| 20.456 | 23.118 | 21.328 | 11.264 | 8.656 | 2.755 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 17.437 | 20.22 | 21.854 | 9.376 | 7.089 | 0 |
| Deferred Revenue Non-Current
| 9.107 | 12.921 | 14.207 | 0 | 0.972 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 77.505 | 0 |
| Other Non-Current Liabilities
| 0.043 | 0.042 | 0.21 | 130.849 | 0.071 | 29.163 |
| Total Non-Current Liabilities
| 26.587 | 33.183 | 36.271 | 140.225 | 85.637 | 29.163 |
| Total Liabilities
| 47.043 | 56.301 | 57.599 | 151.489 | 94.293 | 31.918 |
| Equity: | ||||||
| Preferred Stock
| 159.784 | 227.807 | 307.718 | 105.296 | 77.505 | 28.367 |
| Common Stock
| 0.001 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -364.285 | -295.088 | -206.99 | -108.399 | -47.671 | -17.184 |
| Accumulated Other Comprehensive Income/Loss
| 0.037 | -0.919 | -0.321 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 317.204 | 239.706 | 149.712 | -101.844 | -75.68 | -27.126 |
| Total Shareholders Equity
| 112.741 | 171.506 | 250.119 | -104.947 | -45.846 | -15.943 |
| Total Equity
| 112.741 | 171.506 | 250.119 | -104.947 | -45.846 | -15.943 |
| Total Liabilities & Shareholders Equity
| 159.784 | 227.807 | 307.718 | 46.542 | 48.447 | 15.975 |